학술논문

DNA-PK Promotes the Mitochondrial, Metabolic, and Physical Decline that Occurs During Aging
Document Type
article
Source
Cell Metabolism. 25(5)
Subject
Biochemistry and Cell Biology
Biological Sciences
Genetics
Diabetes
Aging
Prevention
Nutrition
Obesity
Underpinning research
Development of treatments and therapeutic interventions
5.1 Pharmaceuticals
1.1 Normal biological development and functioning
Metabolic and endocrine
AMP-Activated Protein Kinases
Animals
Benzofurans
DNA-Activated Protein Kinase
Diabetes Mellitus
Type 2
Energy Metabolism
Macaca mulatta
Mice
SCID
Mitochondria
Muscle
Muscle
Skeletal
Physical Conditioning
Animal
Quinolines
Rats
AMPK
DNA-PK
HSP90α
aging
calorie restriction
exercise
insulin sensitivity
mitochondria
obesity
skeletal muscle
type 2 diabetes
Medical Biochemistry and Metabolomics
Endocrinology & Metabolism
Biochemistry and cell biology
Medical biochemistry and metabolomics
Language
Abstract
Hallmarks of aging that negatively impact health include weight gain and reduced physical fitness, which can increase insulin resistance and risk for many diseases, including type 2 diabetes. The underlying mechanism(s) for these phenomena is poorly understood. Here we report that aging increases DNA breaks and activates DNA-dependent protein kinase (DNA-PK) in skeletal muscle, which suppresses mitochondrial function, energy metabolism, and physical fitness. DNA-PK phosphorylates threonines 5 and 7 of HSP90α, decreasing its chaperone function for clients such as AMP-activated protein kinase (AMPK), which is critical for mitochondrial biogenesis and energy metabolism. Decreasing DNA-PK activity increases AMPK activity and prevents weight gain, decline of mitochondrial function, and decline of physical fitness in middle-aged mice and protects against type 2 diabetes. In conclusion, DNA-PK is one of the drivers of the metabolic and fitness decline during aging, and therefore DNA-PK inhibitors may have therapeutic potential in obesity and low exercise capacity.